Moderna hits the gas as it begins dosing of 2nd HIV vaccine

Moderna announced Monday it's dosed the first patient in a trial testing its second mRNA HIV jab, less than six weeks after launching human trials for its first jab in January, a proverbial starting gun in the race for a breakthrough HIV therapy that’s now underway between Moderna and Excision BioTherapeutics.